MedPath

力品药业(厦门)股份有限公司

Ownership
-
Established
2012-11-02
Employees
-
Market Cap
-
Website
www.lppharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

7

NMPA:7

Drug Approvals

Aripiprazole Oral Soluble Film

Product Name
阿立哌唑口溶膜
Approval Number
国药准字H20230033
Approval Date
Dec 29, 2023
NMPA

Aripiprazole Oral Soluble Film

Product Name
阿立哌唑口溶膜
Approval Number
国药准字H20230032
Approval Date
Dec 29, 2023
NMPA

Leflunomide Tablets

Product Name
来氟米特片
Approval Number
国药准字H20223488
Approval Date
Jul 7, 2022
NMPA

Clonidine Hydrochloride Sustained-Release Tablets

Product Name
盐酸可乐定缓释片
Approval Number
国药准字H20223470
Approval Date
Jun 30, 2022
NMPA

Dapoxetine Hydrochloride Tablet

Product Name
盐酸达泊西汀片
Approval Number
国药准字H20213156
Approval Date
Mar 9, 2021
NMPA

Pramipexole Dihydrochloride Sustained-release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字H20213114
Approval Date
Feb 2, 2021
NMPA

Pramipexole Dihydrochloride Sustained-release Tablets

Product Name
盐酸普拉克索缓释片
Approval Number
国药准字H20213113
Approval Date
Feb 2, 2021
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.